Karthik Devarajan

Karthik Devarajan has a comprehensive work experience in the pharmaceutical industry. KARTHIK started their career in 2007 as a Quality Assurance Chemist in Process Quality Assurance at Gujarat Liqui Pharmacaps Ltd. KARTHIK then moved on to J.B.CHEMICALS & PHARMACEUTICALS LTD in 2010, where they worked as a Quality Assurance professional in the Quality Management System. In 2011, they joined Aurobindo Pharma Ltd., where they focused on Regulatory Audit and Compliance Management. Here, they handled audits and compliance management, prepared compliance reports, and monitored audit-related CAPAs. KARTHIK also had the opportunity to work with various regulatory organizations such as USFDA, UK MHRA, and FIMEA-Finland. In 2016, Karthik joined Mylan Laboratories Limited as a Team Leader in Quality Assurance. KARTHIK was responsible for inspection management, sterile remediation, and global compliance. KARTHIK led the drug-device combination products and classified products as drugs and devices. Currently, they are working at Bristol Laboratories Ltd. in Corporate Quality Assurance.

Karthik Devarajan completed their education in the field of pharmaceuticals. KARTHIK obtained a Bachelor of Pharmacy (B.Pharm.) degree from The Tamil Nadu Dr. M.G.R. Medical University in Chennai, India from 2003 to 2007. KARTHIK then pursued a Master of Pharmacy (M.Pharmacy) degree from The Tamil Nadu Dr. M.G.R. Medical University from 2008 to 2010.

In addition to their educational qualifications, Karthik Devarajan has obtained several certifications throughout their career. These include certifications such as "N-Nitrosamine Impurities. Latest Update on the Ph. Eur Approach" from The European Directorate for the Quality of Medicines & HealthCare (EDQM) in January 2021, and various COVID-19 related certifications from NSF International in November 2020. KARTHIK has also participated in workshops and conventions such as the "Workshop on Structured Problem Solving & Investigations-Sterile Formulation Drug Products" organized by Mylan in July 2017, and the "66-INDIAN PHARMACEUTICAL CONGRESS" organized by the INDIAN PHARMACEUTICAL ASSOCIATION in January 2015.

Karthik Devarajan's education and certifications show a strong commitment to the pharmaceutical industry and a continuous effort to stay updated on the latest advancements and regulations.